Talasaz's financial involvement in Guardant Health is quite telling. He has waived his cash salary since the inception of waivers in 2021, directing his full commitment towards the company's value. In 2023, his reported compensation was limited to around $26,415...

Talasaz's financial involvement in Guardant Health is quite telling. He has waived his cash salary since the inception of waivers in 2021, directing his full commitment towards the company's value. In 2023, his reported compensation was limited to around $26,415 due to these waivers, an amount primarily covering tax reimbursements related to health insurance and travel. Although he owns zero vested stock or stock options, this arrangement exemplifies his belief in the company’s growth and commitment to long-term objectives. Historically, however, he had a significant stake through performance awards tied to the company’s stock price. These awards are intended to motivate and align executives' incentives with shareholders but currently remain in a state of non-vesting pending specific stock price targets.